Rakovina Therapeutics Announces Extension of Non-Brokered Private Placement
VANCOUVER, British Columbia, March 12, 2026 (GLOBE NEWSWIRE) -- Rakovina Therapeutics Inc. (TSX-V: RKV; FSE: 7JO0) ('Rakovina” or the 'Company”), a biopharmaceutical company advancing innovative cancer therapies through AI-powered drug discovery, is pleased to announce that the TSXV has granted the Company a 30-day extension with respect to its non-brokered private placement financing (the 'Offering”), previously announced on January 27, 2026 and February 20, 2026. The Offering is now expected to close on or before April 9, 2026, or other such date or dates as determined by the Company and acceptable to the TSXV.
